Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma.
Gaißler A, Bochem J, Spreuer J, Ottmann S, Martens A, Amaral T, Wagner NB, Claassen M, Meier F, Terheyden P, Garbe C, Eigentler T, Weide B, Pawelec G, Wistuba-Hamprecht K.
Gaißler A, et al. Among authors: weide b.
J Immunother Cancer. 2023 Jun;11(6):e006802. doi: 10.1136/jitc-2023-006802.
J Immunother Cancer. 2023.
PMID: 37286306
Free PMC article.